Among the highlights of WCLC are final overall survival (OS) data from AstraZeneca's FLAURA 2 study of EGFR inhibitor Tagrisso (osimertinib) given in combination with chemotherapy as a first-line ...
The TCL Nxtpaper 60 Ultra redefines 'Ultra,' prioritizing eye comfort and stylus performance over sheer power.